JP2024522076A5 - - Google Patents
Info
- Publication number
- JP2024522076A5 JP2024522076A5 JP2023571803A JP2023571803A JP2024522076A5 JP 2024522076 A5 JP2024522076 A5 JP 2024522076A5 JP 2023571803 A JP2023571803 A JP 2023571803A JP 2023571803 A JP2023571803 A JP 2023571803A JP 2024522076 A5 JP2024522076 A5 JP 2024522076A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202105379W | 2021-05-21 | ||
| SG10202105379W | 2021-05-21 | ||
| PCT/SG2022/050336 WO2022245299A2 (en) | 2021-05-21 | 2022-05-20 | Anti-ceacam5/6 antigen-binding molecules and methods of treatment thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522076A JP2024522076A (ja) | 2024-06-11 |
| JP2024522076A5 true JP2024522076A5 (https=) | 2025-05-27 |
Family
ID=84141986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571803A Pending JP2024522076A (ja) | 2021-05-21 | 2022-05-20 | 抗ｃｅａｃａｍ５／６抗原結合分子およびその処置方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240238433A1 (https=) |
| EP (1) | EP4341295A4 (https=) |
| JP (1) | JP2024522076A (https=) |
| KR (1) | KR20240012458A (https=) |
| CN (1) | CN117957252A (https=) |
| AU (1) | AU2022277056A1 (https=) |
| BR (1) | BR112023024141A2 (https=) |
| CA (1) | CA3218876A1 (https=) |
| WO (1) | WO2022245299A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025114426A1 (en) | 2023-11-28 | 2025-06-05 | Universite De Strasbourg | Preparation of protein conjugates via one-pot multicomponent reaction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101120021A (zh) * | 2004-12-31 | 2008-02-06 | 基因技术公司 | 结合br3的多肽及其用途 |
| NL2014108B1 (en) * | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
| JP2019522960A (ja) * | 2016-04-21 | 2019-08-22 | アッヴィ・ステムセントルクス・エル・エル・シー | 新規の抗ｂｍｐｒ１ｂ抗体及び使用方法 |
| PT3452507T (pt) * | 2016-05-02 | 2022-12-20 | Prothena Biosciences Ltd | Imunoterapia anti-tau |
| ES2968264T3 (es) * | 2016-10-10 | 2024-05-08 | Singapore Health Serv Pte Ltd | Anticuerpos anti-CEACAM6 y métodos de utilización |
-
2022
- 2022-05-20 KR KR1020237043670A patent/KR20240012458A/ko active Pending
- 2022-05-20 CN CN202280050256.6A patent/CN117957252A/zh active Pending
- 2022-05-20 EP EP22805100.9A patent/EP4341295A4/en active Pending
- 2022-05-20 JP JP2023571803A patent/JP2024522076A/ja active Pending
- 2022-05-20 US US18/562,788 patent/US20240238433A1/en active Pending
- 2022-05-20 AU AU2022277056A patent/AU2022277056A1/en active Pending
- 2022-05-20 WO PCT/SG2022/050336 patent/WO2022245299A2/en not_active Ceased
- 2022-05-20 BR BR112023024141A patent/BR112023024141A2/pt unknown
- 2022-05-20 CA CA3218876A patent/CA3218876A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10792370B2 (en) | Antibody-drug conjugate | |
| EP4087613A1 (en) | Anti-slc34a2 antibodies, antibody drug conjugates, and methods of use thereof | |
| CA2995673A1 (en) | Internalizing moieties for treatment of cancer | |
| TWI541022B (zh) | 針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法 | |
| JP2010535713A5 (https=) | ||
| JP2017526339A5 (https=) | ||
| JP6811706B2 (ja) | Ｅｐｈａ４に対するヒトモノクローナル抗体及びそれらの使用 | |
| JP6998470B2 (ja) | Ｆｏｌｒ１に特異的に結合する抗体及びその用途 | |
| JP2023518153A5 (https=) | ||
| TW202011998A (zh) | 利用抗體－藥物結合物投予之轉移性腦腫瘤之治療 | |
| WO2018232349A1 (en) | Antibody-drug conjugates containing anti-globo h antibodies and uses thereof | |
| JP2017503763A5 (https=) | ||
| JP2024524870A5 (https=) | ||
| US12053530B2 (en) | Plectin-1 binding antibodies and uses thereof | |
| AU2021289442A1 (en) | Anti-human neurotensin receptor 1 antibody and use thereof | |
| JP2024522076A5 (https=) | ||
| JP2009544574A5 (https=) | ||
| US20220289825A1 (en) | FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOF | |
| JP2022534808A5 (https=) | ||
| JP2021516670A (ja) | 抗ｔｒａｉｌｒ２抗体−毒素−複合体およびその抗腫瘍治療における薬物用途 | |
| JP2024527974A (ja) | 小細胞肺がんを治療する薬物の組み合わせ | |
| CN103417965B (zh) | 一种含有抗vegf抗体的药物组合物 | |
| JP2026512687A (ja) | ヒト化ｌ１ｃａｍ抗体－薬物複合体 | |
| JP2024523885A5 (https=) | ||
| TW201642904A (zh) | 含抗ｆｇｆｒ２抗體及其他藥劑之組成物 |